Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Prognosis Factors in Probands With an FBN1 Mutation Diagnosed Before the Age of 1 Year

Identifieur interne : 001602 ( PascalFrancis/Corpus ); précédent : 001601; suivant : 001603

Prognosis Factors in Probands With an FBN1 Mutation Diagnosed Before the Age of 1 Year

Auteurs : Chantal Stheneur ; Laurence Faivre ; Gwenaelle Collod-Beroud ; Elodie Gautier ; Christine Binquet ; Claire Bonithon-Kopp ; Mireille Claustres ; Anne H. Child ; Eloisa Arbustini ; Lesley C. Ades ; Uta Francke ; Karin Mayer ; Mine Arslan-Kirchner ; Anne De Paepe ; Bertrand Chevallier ; Damien Bonnet ; Guillaume Jondeau ; Catherine Boileau

Source :

RBID : Pascal:12-0086552

Descripteurs français

English descriptors

Abstract

Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder. Diagnostic criteria of neonatal MFS (nMFS), the most severe form, are still debated. The aim of our study was to search for clinical and molecular prognostic factors that could be associated with length of survival. Probands ascertained via the framework of the Universal Marfan database-FBN1, diagnosed before the age of 1 y and presenting with cardiovascular features (aortic root dilatation or valvular insufficiency) were included in this study. Clinical and molecular data were correlated to survival. Among the 60 individuals, 38 had died, 82% died before the age of 1 y, mostly because of congestive heart failure. Three probands reached adult-hood. Valvular insufficiencies and diaphragmatic hernia were predictive of shorter life expectancy. Two FUN1 mutations were found outside of the exon 24-32 region (in exons 4 and 21). Mutations in exons 25-26 were overrepresented and were associated with shorter survival (p = 0.03). We report the largest genotyped series of probands with MFS diagnosed before 1 y of life. In this population, factors significantly associated with shorter survival are presence of valvular insufficiencies or diaphragmatic hernia in addition to a mutation in exons 25 or 26.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0031-3998
A02 01      @0 PEREBL
A03   1    @0 Pediatr. res.
A05       @2 69
A06       @2 3
A08 01  1  ENG  @1 Prognosis Factors in Probands With an FBN1 Mutation Diagnosed Before the Age of 1 Year
A11 01  1    @1 STHENEUR (Chantal)
A11 02  1    @1 FAIVRE (Laurence)
A11 03  1    @1 COLLOD-BEROUD (Gwenaelle)
A11 04  1    @1 GAUTIER (Elodie)
A11 05  1    @1 BINQUET (Christine)
A11 06  1    @1 BONITHON-KOPP (Claire)
A11 07  1    @1 CLAUSTRES (Mireille)
A11 08  1    @1 CHILD (Anne H.)
A11 09  1    @1 ARBUSTINI (Eloisa)
A11 10  1    @1 ADES (Lesley C.)
A11 11  1    @1 FRANCKE (Uta)
A11 12  1    @1 MAYER (Karin)
A11 13  1    @1 ARSLAN-KIRCHNER (Mine)
A11 14  1    @1 DE PAEPE (Anne)
A11 15  1    @1 CHEVALLIER (Bertrand)
A11 16  1    @1 BONNET (Damien)
A11 17  1    @1 JONDEAU (Guillaume)
A11 18  1    @1 BOILEAU (Catherine)
A14 01      @1 Service de Pédiatrie Hôpital Ambroise Paré @2 Boulogne, 92100 @3 FRA @Z 1 aut. @Z 15 aut.
A14 02      @1 Consultation multidisciplinaire Marfan Hôpital Bichat @2 Paris, 75018 @3 FRA @Z 17 aut.
A14 03      @1 Centre de Génétique CHUDijon @2 Dijon, 21000 @3 FRA @Z 2 aut.
A14 04      @1 Centre d'Investigation Clinique- Epidémiologie-Clinique/essais cliniques CHU Dijon @2 Dijon, 21000 @3 FRA @Z 4 aut. @Z 5 aut. @Z 6 aut. @Z 18 aut.
A14 05      @1 INSERM, U827 Université Montpellier @2 Montpellier, 34000 @3 FRA @Z 3 aut. @Z 7 aut.
A14 06      @1 Department of Cardiological Sciences St Georges Hospital @2 London SW17 0RE @3 GBR @Z 8 aut.
A14 07      @1 Molecular Diagnostic Division IRCCS Foundation San Matteo Hospital @2 Pavia, 27100 @3 ITA @Z 9 aut.
A14 08      @1 Marfan Research Group and Department of Clinical Genetics Children's Hospital @2 Westmead, New South Wales 2145 @3 AUS @Z 10 aut.
A14 09      @1 Department of Genetics and Pediatrics Stanford University Medical Center @2 Stanford, California 94305 @3 USA @Z 11 aut.
A14 10      @1 Center for Human Genetics and Laboratory Medicine @2 Martinsried, 82152 @3 DEU @Z 12 aut.
A14 11      @1 Institut für Humangenetik Hannover Medical School @2 Hannover, 30625 @3 DEU @Z 13 aut.
A14 12      @1 Center for Medical Genetics Ghent University Hospital @2 Ghent, 9000 @3 BEL @Z 14 aut.
A14 13      @1 Service de Cardiologie Pediatrique Hôpital Necker-Enfants-Malades @2 Paris, 75015 @3 FRA @Z 16 aut.
A20       @1 265-270
A21       @1 2011
A23 01      @0 ENG
A43 01      @1 INIST @2 3956 @5 354000192015580150
A44       @0 0000 @1 © 2012 INIST-CNRS. All rights reserved.
A45       @0 23 ref.
A47 01  1    @0 12-0086552
A60       @1 P
A61       @0 A
A64 01  1    @0 Pediatric research
A66 01      @0 USA
C01 01    ENG  @0 Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder. Diagnostic criteria of neonatal MFS (nMFS), the most severe form, are still debated. The aim of our study was to search for clinical and molecular prognostic factors that could be associated with length of survival. Probands ascertained via the framework of the Universal Marfan database-FBN1, diagnosed before the age of 1 y and presenting with cardiovascular features (aortic root dilatation or valvular insufficiency) were included in this study. Clinical and molecular data were correlated to survival. Among the 60 individuals, 38 had died, 82% died before the age of 1 y, mostly because of congestive heart failure. Three probands reached adult-hood. Valvular insufficiencies and diaphragmatic hernia were predictive of shorter life expectancy. Two FUN1 mutations were found outside of the exon 24-32 region (in exons 4 and 21). Mutations in exons 25-26 were overrepresented and were associated with shorter survival (p = 0.03). We report the largest genotyped series of probands with MFS diagnosed before 1 y of life. In this population, factors significantly associated with shorter survival are presence of valvular insufficiencies or diaphragmatic hernia in addition to a mutation in exons 25 or 26.
C02 01  X    @0 002B01
C03 01  X  FRE  @0 Pronostic @5 02
C03 01  X  ENG  @0 Prognosis @5 02
C03 01  X  SPA  @0 Pronóstico @5 02
C03 02  X  FRE  @0 Mutation @5 03
C03 02  X  ENG  @0 Mutation @5 03
C03 02  X  SPA  @0 Mutación @5 03
C03 03  X  FRE  @0 Génétique @5 05
C03 03  X  ENG  @0 Genetics @5 05
C03 03  X  SPA  @0 Genética @5 05
C03 04  X  FRE  @0 Diagnostic @5 06
C03 04  X  ENG  @0 Diagnosis @5 06
C03 04  X  SPA  @0 Diagnóstico @5 06
C03 05  X  FRE  @0 Age @5 08
C03 05  X  ENG  @0 Age @5 08
C03 05  X  SPA  @0 Edad @5 08
C03 06  X  FRE  @0 Pédiatrie @5 09
C03 06  X  ENG  @0 Pediatrics @5 09
C03 06  X  SPA  @0 Pediatría @5 09
N21       @1 065
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 12-0086552 INIST
ET : Prognosis Factors in Probands With an FBN1 Mutation Diagnosed Before the Age of 1 Year
AU : STHENEUR (Chantal); FAIVRE (Laurence); COLLOD-BEROUD (Gwenaelle); GAUTIER (Elodie); BINQUET (Christine); BONITHON-KOPP (Claire); CLAUSTRES (Mireille); CHILD (Anne H.); ARBUSTINI (Eloisa); ADES (Lesley C.); FRANCKE (Uta); MAYER (Karin); ARSLAN-KIRCHNER (Mine); DE PAEPE (Anne); CHEVALLIER (Bertrand); BONNET (Damien); JONDEAU (Guillaume); BOILEAU (Catherine)
AF : Service de Pédiatrie Hôpital Ambroise Paré/Boulogne, 92100/France (1 aut., 15 aut.); Consultation multidisciplinaire Marfan Hôpital Bichat/Paris, 75018/France (17 aut.); Centre de Génétique CHUDijon/Dijon, 21000/France (2 aut.); Centre d'Investigation Clinique- Epidémiologie-Clinique/essais cliniques CHU Dijon/Dijon, 21000/France (4 aut., 5 aut., 6 aut., 18 aut.); INSERM, U827 Université Montpellier/Montpellier, 34000/France (3 aut., 7 aut.); Department of Cardiological Sciences St Georges Hospital/London SW17 0RE/Royaume-Uni (8 aut.); Molecular Diagnostic Division IRCCS Foundation San Matteo Hospital/Pavia, 27100/Italie (9 aut.); Marfan Research Group and Department of Clinical Genetics Children's Hospital/Westmead, New South Wales 2145/Australie (10 aut.); Department of Genetics and Pediatrics Stanford University Medical Center/Stanford, California 94305/Etats-Unis (11 aut.); Center for Human Genetics and Laboratory Medicine/Martinsried, 82152/Allemagne (12 aut.); Institut für Humangenetik Hannover Medical School/Hannover, 30625/Allemagne (13 aut.); Center for Medical Genetics Ghent University Hospital/Ghent, 9000/Belgique (14 aut.); Service de Cardiologie Pediatrique Hôpital Necker-Enfants-Malades/Paris, 75015/France (16 aut.)
DT : Publication en série; Niveau analytique
SO : Pediatric research; ISSN 0031-3998; Coden PEREBL; Etats-Unis; Da. 2011; Vol. 69; No. 3; Pp. 265-270; Bibl. 23 ref.
LA : Anglais
EA : Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder. Diagnostic criteria of neonatal MFS (nMFS), the most severe form, are still debated. The aim of our study was to search for clinical and molecular prognostic factors that could be associated with length of survival. Probands ascertained via the framework of the Universal Marfan database-FBN1, diagnosed before the age of 1 y and presenting with cardiovascular features (aortic root dilatation or valvular insufficiency) were included in this study. Clinical and molecular data were correlated to survival. Among the 60 individuals, 38 had died, 82% died before the age of 1 y, mostly because of congestive heart failure. Three probands reached adult-hood. Valvular insufficiencies and diaphragmatic hernia were predictive of shorter life expectancy. Two FUN1 mutations were found outside of the exon 24-32 region (in exons 4 and 21). Mutations in exons 25-26 were overrepresented and were associated with shorter survival (p = 0.03). We report the largest genotyped series of probands with MFS diagnosed before 1 y of life. In this population, factors significantly associated with shorter survival are presence of valvular insufficiencies or diaphragmatic hernia in addition to a mutation in exons 25 or 26.
CC : 002B01
FD : Pronostic; Mutation; Génétique; Diagnostic; Age; Pédiatrie
ED : Prognosis; Mutation; Genetics; Diagnosis; Age; Pediatrics
SD : Pronóstico; Mutación; Genética; Diagnóstico; Edad; Pediatría
LO : INIST-3956.354000192015580150
ID : 12-0086552

Links to Exploration step

Pascal:12-0086552

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Prognosis Factors in Probands With an FBN1 Mutation Diagnosed Before the Age of 1 Year</title>
<author>
<name sortKey="Stheneur, Chantal" sort="Stheneur, Chantal" uniqKey="Stheneur C" first="Chantal" last="Stheneur">Chantal Stheneur</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Service de Pédiatrie Hôpital Ambroise Paré</s1>
<s2>Boulogne, 92100</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Faivre, Laurence" sort="Faivre, Laurence" uniqKey="Faivre L" first="Laurence" last="Faivre">Laurence Faivre</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Centre de Génétique CHUDijon</s1>
<s2>Dijon, 21000</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Collod Beroud, Gwenaelle" sort="Collod Beroud, Gwenaelle" uniqKey="Collod Beroud G" first="Gwenaelle" last="Collod-Beroud">Gwenaelle Collod-Beroud</name>
<affiliation>
<inist:fA14 i1="05">
<s1>INSERM, U827 Université Montpellier</s1>
<s2>Montpellier, 34000</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Gautier, Elodie" sort="Gautier, Elodie" uniqKey="Gautier E" first="Elodie" last="Gautier">Elodie Gautier</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Centre d'Investigation Clinique- Epidémiologie-Clinique/essais cliniques CHU Dijon</s1>
<s2>Dijon, 21000</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>18 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Binquet, Christine" sort="Binquet, Christine" uniqKey="Binquet C" first="Christine" last="Binquet">Christine Binquet</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Centre d'Investigation Clinique- Epidémiologie-Clinique/essais cliniques CHU Dijon</s1>
<s2>Dijon, 21000</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>18 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Bonithon Kopp, Claire" sort="Bonithon Kopp, Claire" uniqKey="Bonithon Kopp C" first="Claire" last="Bonithon-Kopp">Claire Bonithon-Kopp</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Centre d'Investigation Clinique- Epidémiologie-Clinique/essais cliniques CHU Dijon</s1>
<s2>Dijon, 21000</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>18 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Claustres, Mireille" sort="Claustres, Mireille" uniqKey="Claustres M" first="Mireille" last="Claustres">Mireille Claustres</name>
<affiliation>
<inist:fA14 i1="05">
<s1>INSERM, U827 Université Montpellier</s1>
<s2>Montpellier, 34000</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Child, Anne H" sort="Child, Anne H" uniqKey="Child A" first="Anne H." last="Child">Anne H. Child</name>
<affiliation>
<inist:fA14 i1="06">
<s1>Department of Cardiological Sciences St Georges Hospital</s1>
<s2>London SW17 0RE</s2>
<s3>GBR</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Arbustini, Eloisa" sort="Arbustini, Eloisa" uniqKey="Arbustini E" first="Eloisa" last="Arbustini">Eloisa Arbustini</name>
<affiliation>
<inist:fA14 i1="07">
<s1>Molecular Diagnostic Division IRCCS Foundation San Matteo Hospital</s1>
<s2>Pavia, 27100</s2>
<s3>ITA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Ades, Lesley C" sort="Ades, Lesley C" uniqKey="Ades L" first="Lesley C." last="Ades">Lesley C. Ades</name>
<affiliation>
<inist:fA14 i1="08">
<s1>Marfan Research Group and Department of Clinical Genetics Children's Hospital</s1>
<s2>Westmead, New South Wales 2145</s2>
<s3>AUS</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Francke, Uta" sort="Francke, Uta" uniqKey="Francke U" first="Uta" last="Francke">Uta Francke</name>
<affiliation>
<inist:fA14 i1="09">
<s1>Department of Genetics and Pediatrics Stanford University Medical Center</s1>
<s2>Stanford, California 94305</s2>
<s3>USA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Mayer, Karin" sort="Mayer, Karin" uniqKey="Mayer K" first="Karin" last="Mayer">Karin Mayer</name>
<affiliation>
<inist:fA14 i1="10">
<s1>Center for Human Genetics and Laboratory Medicine</s1>
<s2>Martinsried, 82152</s2>
<s3>DEU</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Arslan Kirchner, Mine" sort="Arslan Kirchner, Mine" uniqKey="Arslan Kirchner M" first="Mine" last="Arslan-Kirchner">Mine Arslan-Kirchner</name>
<affiliation>
<inist:fA14 i1="11">
<s1>Institut für Humangenetik Hannover Medical School</s1>
<s2>Hannover, 30625</s2>
<s3>DEU</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="De Paepe, Anne" sort="De Paepe, Anne" uniqKey="De Paepe A" first="Anne" last="De Paepe">Anne De Paepe</name>
<affiliation>
<inist:fA14 i1="12">
<s1>Center for Medical Genetics Ghent University Hospital</s1>
<s2>Ghent, 9000</s2>
<s3>BEL</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Chevallier, Bertrand" sort="Chevallier, Bertrand" uniqKey="Chevallier B" first="Bertrand" last="Chevallier">Bertrand Chevallier</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Service de Pédiatrie Hôpital Ambroise Paré</s1>
<s2>Boulogne, 92100</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Bonnet, Damien" sort="Bonnet, Damien" uniqKey="Bonnet D" first="Damien" last="Bonnet">Damien Bonnet</name>
<affiliation>
<inist:fA14 i1="13">
<s1>Service de Cardiologie Pediatrique Hôpital Necker-Enfants-Malades</s1>
<s2>Paris, 75015</s2>
<s3>FRA</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Jondeau, Guillaume" sort="Jondeau, Guillaume" uniqKey="Jondeau G" first="Guillaume" last="Jondeau">Guillaume Jondeau</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Consultation multidisciplinaire Marfan Hôpital Bichat</s1>
<s2>Paris, 75018</s2>
<s3>FRA</s3>
<sZ>17 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Boileau, Catherine" sort="Boileau, Catherine" uniqKey="Boileau C" first="Catherine" last="Boileau">Catherine Boileau</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Centre d'Investigation Clinique- Epidémiologie-Clinique/essais cliniques CHU Dijon</s1>
<s2>Dijon, 21000</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>18 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">12-0086552</idno>
<date when="2011">2011</date>
<idno type="stanalyst">PASCAL 12-0086552 INIST</idno>
<idno type="RBID">Pascal:12-0086552</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001602</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Prognosis Factors in Probands With an FBN1 Mutation Diagnosed Before the Age of 1 Year</title>
<author>
<name sortKey="Stheneur, Chantal" sort="Stheneur, Chantal" uniqKey="Stheneur C" first="Chantal" last="Stheneur">Chantal Stheneur</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Service de Pédiatrie Hôpital Ambroise Paré</s1>
<s2>Boulogne, 92100</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Faivre, Laurence" sort="Faivre, Laurence" uniqKey="Faivre L" first="Laurence" last="Faivre">Laurence Faivre</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Centre de Génétique CHUDijon</s1>
<s2>Dijon, 21000</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Collod Beroud, Gwenaelle" sort="Collod Beroud, Gwenaelle" uniqKey="Collod Beroud G" first="Gwenaelle" last="Collod-Beroud">Gwenaelle Collod-Beroud</name>
<affiliation>
<inist:fA14 i1="05">
<s1>INSERM, U827 Université Montpellier</s1>
<s2>Montpellier, 34000</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Gautier, Elodie" sort="Gautier, Elodie" uniqKey="Gautier E" first="Elodie" last="Gautier">Elodie Gautier</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Centre d'Investigation Clinique- Epidémiologie-Clinique/essais cliniques CHU Dijon</s1>
<s2>Dijon, 21000</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>18 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Binquet, Christine" sort="Binquet, Christine" uniqKey="Binquet C" first="Christine" last="Binquet">Christine Binquet</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Centre d'Investigation Clinique- Epidémiologie-Clinique/essais cliniques CHU Dijon</s1>
<s2>Dijon, 21000</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>18 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Bonithon Kopp, Claire" sort="Bonithon Kopp, Claire" uniqKey="Bonithon Kopp C" first="Claire" last="Bonithon-Kopp">Claire Bonithon-Kopp</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Centre d'Investigation Clinique- Epidémiologie-Clinique/essais cliniques CHU Dijon</s1>
<s2>Dijon, 21000</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>18 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Claustres, Mireille" sort="Claustres, Mireille" uniqKey="Claustres M" first="Mireille" last="Claustres">Mireille Claustres</name>
<affiliation>
<inist:fA14 i1="05">
<s1>INSERM, U827 Université Montpellier</s1>
<s2>Montpellier, 34000</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Child, Anne H" sort="Child, Anne H" uniqKey="Child A" first="Anne H." last="Child">Anne H. Child</name>
<affiliation>
<inist:fA14 i1="06">
<s1>Department of Cardiological Sciences St Georges Hospital</s1>
<s2>London SW17 0RE</s2>
<s3>GBR</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Arbustini, Eloisa" sort="Arbustini, Eloisa" uniqKey="Arbustini E" first="Eloisa" last="Arbustini">Eloisa Arbustini</name>
<affiliation>
<inist:fA14 i1="07">
<s1>Molecular Diagnostic Division IRCCS Foundation San Matteo Hospital</s1>
<s2>Pavia, 27100</s2>
<s3>ITA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Ades, Lesley C" sort="Ades, Lesley C" uniqKey="Ades L" first="Lesley C." last="Ades">Lesley C. Ades</name>
<affiliation>
<inist:fA14 i1="08">
<s1>Marfan Research Group and Department of Clinical Genetics Children's Hospital</s1>
<s2>Westmead, New South Wales 2145</s2>
<s3>AUS</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Francke, Uta" sort="Francke, Uta" uniqKey="Francke U" first="Uta" last="Francke">Uta Francke</name>
<affiliation>
<inist:fA14 i1="09">
<s1>Department of Genetics and Pediatrics Stanford University Medical Center</s1>
<s2>Stanford, California 94305</s2>
<s3>USA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Mayer, Karin" sort="Mayer, Karin" uniqKey="Mayer K" first="Karin" last="Mayer">Karin Mayer</name>
<affiliation>
<inist:fA14 i1="10">
<s1>Center for Human Genetics and Laboratory Medicine</s1>
<s2>Martinsried, 82152</s2>
<s3>DEU</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Arslan Kirchner, Mine" sort="Arslan Kirchner, Mine" uniqKey="Arslan Kirchner M" first="Mine" last="Arslan-Kirchner">Mine Arslan-Kirchner</name>
<affiliation>
<inist:fA14 i1="11">
<s1>Institut für Humangenetik Hannover Medical School</s1>
<s2>Hannover, 30625</s2>
<s3>DEU</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="De Paepe, Anne" sort="De Paepe, Anne" uniqKey="De Paepe A" first="Anne" last="De Paepe">Anne De Paepe</name>
<affiliation>
<inist:fA14 i1="12">
<s1>Center for Medical Genetics Ghent University Hospital</s1>
<s2>Ghent, 9000</s2>
<s3>BEL</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Chevallier, Bertrand" sort="Chevallier, Bertrand" uniqKey="Chevallier B" first="Bertrand" last="Chevallier">Bertrand Chevallier</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Service de Pédiatrie Hôpital Ambroise Paré</s1>
<s2>Boulogne, 92100</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Bonnet, Damien" sort="Bonnet, Damien" uniqKey="Bonnet D" first="Damien" last="Bonnet">Damien Bonnet</name>
<affiliation>
<inist:fA14 i1="13">
<s1>Service de Cardiologie Pediatrique Hôpital Necker-Enfants-Malades</s1>
<s2>Paris, 75015</s2>
<s3>FRA</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Jondeau, Guillaume" sort="Jondeau, Guillaume" uniqKey="Jondeau G" first="Guillaume" last="Jondeau">Guillaume Jondeau</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Consultation multidisciplinaire Marfan Hôpital Bichat</s1>
<s2>Paris, 75018</s2>
<s3>FRA</s3>
<sZ>17 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Boileau, Catherine" sort="Boileau, Catherine" uniqKey="Boileau C" first="Catherine" last="Boileau">Catherine Boileau</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Centre d'Investigation Clinique- Epidémiologie-Clinique/essais cliniques CHU Dijon</s1>
<s2>Dijon, 21000</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>18 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Pediatric research</title>
<title level="j" type="abbreviated">Pediatr. res.</title>
<idno type="ISSN">0031-3998</idno>
<imprint>
<date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Pediatric research</title>
<title level="j" type="abbreviated">Pediatr. res.</title>
<idno type="ISSN">0031-3998</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Age</term>
<term>Diagnosis</term>
<term>Genetics</term>
<term>Mutation</term>
<term>Pediatrics</term>
<term>Prognosis</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Pronostic</term>
<term>Mutation</term>
<term>Génétique</term>
<term>Diagnostic</term>
<term>Age</term>
<term>Pédiatrie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder. Diagnostic criteria of neonatal MFS (nMFS), the most severe form, are still debated. The aim of our study was to search for clinical and molecular prognostic factors that could be associated with length of survival. Probands ascertained via the framework of the Universal Marfan database-FBN1, diagnosed before the age of 1 y and presenting with cardiovascular features (aortic root dilatation or valvular insufficiency) were included in this study. Clinical and molecular data were correlated to survival. Among the 60 individuals, 38 had died, 82% died before the age of 1 y, mostly because of congestive heart failure. Three probands reached adult-hood. Valvular insufficiencies and diaphragmatic hernia were predictive of shorter life expectancy. Two FUN1 mutations were found outside of the exon 24-32 region (in exons 4 and 21). Mutations in exons 25-26 were overrepresented and were associated with shorter survival (p = 0.03). We report the largest genotyped series of probands with MFS diagnosed before 1 y of life. In this population, factors significantly associated with shorter survival are presence of valvular insufficiencies or diaphragmatic hernia in addition to a mutation in exons 25 or 26.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0031-3998</s0>
</fA01>
<fA02 i1="01">
<s0>PEREBL</s0>
</fA02>
<fA03 i2="1">
<s0>Pediatr. res.</s0>
</fA03>
<fA05>
<s2>69</s2>
</fA05>
<fA06>
<s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Prognosis Factors in Probands With an FBN1 Mutation Diagnosed Before the Age of 1 Year</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>STHENEUR (Chantal)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>FAIVRE (Laurence)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>COLLOD-BEROUD (Gwenaelle)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>GAUTIER (Elodie)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>BINQUET (Christine)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>BONITHON-KOPP (Claire)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>CLAUSTRES (Mireille)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>CHILD (Anne H.)</s1>
</fA11>
<fA11 i1="09" i2="1">
<s1>ARBUSTINI (Eloisa)</s1>
</fA11>
<fA11 i1="10" i2="1">
<s1>ADES (Lesley C.)</s1>
</fA11>
<fA11 i1="11" i2="1">
<s1>FRANCKE (Uta)</s1>
</fA11>
<fA11 i1="12" i2="1">
<s1>MAYER (Karin)</s1>
</fA11>
<fA11 i1="13" i2="1">
<s1>ARSLAN-KIRCHNER (Mine)</s1>
</fA11>
<fA11 i1="14" i2="1">
<s1>DE PAEPE (Anne)</s1>
</fA11>
<fA11 i1="15" i2="1">
<s1>CHEVALLIER (Bertrand)</s1>
</fA11>
<fA11 i1="16" i2="1">
<s1>BONNET (Damien)</s1>
</fA11>
<fA11 i1="17" i2="1">
<s1>JONDEAU (Guillaume)</s1>
</fA11>
<fA11 i1="18" i2="1">
<s1>BOILEAU (Catherine)</s1>
</fA11>
<fA14 i1="01">
<s1>Service de Pédiatrie Hôpital Ambroise Paré</s1>
<s2>Boulogne, 92100</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>15 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Consultation multidisciplinaire Marfan Hôpital Bichat</s1>
<s2>Paris, 75018</s2>
<s3>FRA</s3>
<sZ>17 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Centre de Génétique CHUDijon</s1>
<s2>Dijon, 21000</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Centre d'Investigation Clinique- Epidémiologie-Clinique/essais cliniques CHU Dijon</s1>
<s2>Dijon, 21000</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>18 aut.</sZ>
</fA14>
<fA14 i1="05">
<s1>INSERM, U827 Université Montpellier</s1>
<s2>Montpellier, 34000</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="06">
<s1>Department of Cardiological Sciences St Georges Hospital</s1>
<s2>London SW17 0RE</s2>
<s3>GBR</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="07">
<s1>Molecular Diagnostic Division IRCCS Foundation San Matteo Hospital</s1>
<s2>Pavia, 27100</s2>
<s3>ITA</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="08">
<s1>Marfan Research Group and Department of Clinical Genetics Children's Hospital</s1>
<s2>Westmead, New South Wales 2145</s2>
<s3>AUS</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="09">
<s1>Department of Genetics and Pediatrics Stanford University Medical Center</s1>
<s2>Stanford, California 94305</s2>
<s3>USA</s3>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="10">
<s1>Center for Human Genetics and Laboratory Medicine</s1>
<s2>Martinsried, 82152</s2>
<s3>DEU</s3>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="11">
<s1>Institut für Humangenetik Hannover Medical School</s1>
<s2>Hannover, 30625</s2>
<s3>DEU</s3>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="12">
<s1>Center for Medical Genetics Ghent University Hospital</s1>
<s2>Ghent, 9000</s2>
<s3>BEL</s3>
<sZ>14 aut.</sZ>
</fA14>
<fA14 i1="13">
<s1>Service de Cardiologie Pediatrique Hôpital Necker-Enfants-Malades</s1>
<s2>Paris, 75015</s2>
<s3>FRA</s3>
<sZ>16 aut.</sZ>
</fA14>
<fA20>
<s1>265-270</s1>
</fA20>
<fA21>
<s1>2011</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>3956</s2>
<s5>354000192015580150</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2012 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>23 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>12-0086552</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Pediatric research</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder. Diagnostic criteria of neonatal MFS (nMFS), the most severe form, are still debated. The aim of our study was to search for clinical and molecular prognostic factors that could be associated with length of survival. Probands ascertained via the framework of the Universal Marfan database-FBN1, diagnosed before the age of 1 y and presenting with cardiovascular features (aortic root dilatation or valvular insufficiency) were included in this study. Clinical and molecular data were correlated to survival. Among the 60 individuals, 38 had died, 82% died before the age of 1 y, mostly because of congestive heart failure. Three probands reached adult-hood. Valvular insufficiencies and diaphragmatic hernia were predictive of shorter life expectancy. Two FUN1 mutations were found outside of the exon 24-32 region (in exons 4 and 21). Mutations in exons 25-26 were overrepresented and were associated with shorter survival (p = 0.03). We report the largest genotyped series of probands with MFS diagnosed before 1 y of life. In this population, factors significantly associated with shorter survival are presence of valvular insufficiencies or diaphragmatic hernia in addition to a mutation in exons 25 or 26.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B01</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Pronostic</s0>
<s5>02</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Prognosis</s0>
<s5>02</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Pronóstico</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Mutation</s0>
<s5>03</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Mutation</s0>
<s5>03</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Mutación</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Génétique</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Genetics</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Genética</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Diagnostic</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Diagnosis</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Diagnóstico</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Age</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Age</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Edad</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Pédiatrie</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Pediatrics</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Pediatría</s0>
<s5>09</s5>
</fC03>
<fN21>
<s1>065</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 12-0086552 INIST</NO>
<ET>Prognosis Factors in Probands With an FBN1 Mutation Diagnosed Before the Age of 1 Year</ET>
<AU>STHENEUR (Chantal); FAIVRE (Laurence); COLLOD-BEROUD (Gwenaelle); GAUTIER (Elodie); BINQUET (Christine); BONITHON-KOPP (Claire); CLAUSTRES (Mireille); CHILD (Anne H.); ARBUSTINI (Eloisa); ADES (Lesley C.); FRANCKE (Uta); MAYER (Karin); ARSLAN-KIRCHNER (Mine); DE PAEPE (Anne); CHEVALLIER (Bertrand); BONNET (Damien); JONDEAU (Guillaume); BOILEAU (Catherine)</AU>
<AF>Service de Pédiatrie Hôpital Ambroise Paré/Boulogne, 92100/France (1 aut., 15 aut.); Consultation multidisciplinaire Marfan Hôpital Bichat/Paris, 75018/France (17 aut.); Centre de Génétique CHUDijon/Dijon, 21000/France (2 aut.); Centre d'Investigation Clinique- Epidémiologie-Clinique/essais cliniques CHU Dijon/Dijon, 21000/France (4 aut., 5 aut., 6 aut., 18 aut.); INSERM, U827 Université Montpellier/Montpellier, 34000/France (3 aut., 7 aut.); Department of Cardiological Sciences St Georges Hospital/London SW17 0RE/Royaume-Uni (8 aut.); Molecular Diagnostic Division IRCCS Foundation San Matteo Hospital/Pavia, 27100/Italie (9 aut.); Marfan Research Group and Department of Clinical Genetics Children's Hospital/Westmead, New South Wales 2145/Australie (10 aut.); Department of Genetics and Pediatrics Stanford University Medical Center/Stanford, California 94305/Etats-Unis (11 aut.); Center for Human Genetics and Laboratory Medicine/Martinsried, 82152/Allemagne (12 aut.); Institut für Humangenetik Hannover Medical School/Hannover, 30625/Allemagne (13 aut.); Center for Medical Genetics Ghent University Hospital/Ghent, 9000/Belgique (14 aut.); Service de Cardiologie Pediatrique Hôpital Necker-Enfants-Malades/Paris, 75015/France (16 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Pediatric research; ISSN 0031-3998; Coden PEREBL; Etats-Unis; Da. 2011; Vol. 69; No. 3; Pp. 265-270; Bibl. 23 ref.</SO>
<LA>Anglais</LA>
<EA>Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder. Diagnostic criteria of neonatal MFS (nMFS), the most severe form, are still debated. The aim of our study was to search for clinical and molecular prognostic factors that could be associated with length of survival. Probands ascertained via the framework of the Universal Marfan database-FBN1, diagnosed before the age of 1 y and presenting with cardiovascular features (aortic root dilatation or valvular insufficiency) were included in this study. Clinical and molecular data were correlated to survival. Among the 60 individuals, 38 had died, 82% died before the age of 1 y, mostly because of congestive heart failure. Three probands reached adult-hood. Valvular insufficiencies and diaphragmatic hernia were predictive of shorter life expectancy. Two FUN1 mutations were found outside of the exon 24-32 region (in exons 4 and 21). Mutations in exons 25-26 were overrepresented and were associated with shorter survival (p = 0.03). We report the largest genotyped series of probands with MFS diagnosed before 1 y of life. In this population, factors significantly associated with shorter survival are presence of valvular insufficiencies or diaphragmatic hernia in addition to a mutation in exons 25 or 26.</EA>
<CC>002B01</CC>
<FD>Pronostic; Mutation; Génétique; Diagnostic; Age; Pédiatrie</FD>
<ED>Prognosis; Mutation; Genetics; Diagnosis; Age; Pediatrics</ED>
<SD>Pronóstico; Mutación; Genética; Diagnóstico; Edad; Pediatría</SD>
<LO>INIST-3956.354000192015580150</LO>
<ID>12-0086552</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001602 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001602 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:12-0086552
   |texte=   Prognosis Factors in Probands With an FBN1 Mutation Diagnosed Before the Age of 1 Year
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024